SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 750 participants.
Also called NCT02401451
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 750 participants
- Sponsor
- Cardiocity Limited
- Registry
-
NCT02401451
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02401451. Allocation not applicable; no masking; primary purpose screening. Start 2014-10 (registry gives no type); primary completion 2016-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF])
- Acronym
- SL-AF
- Condition
- Atrial Fibrillation
- Intervention (Device)
- RhythmPadGP
- Lead sponsor
- Cardiocity Limited
Record details
- Record id
cardio:ct-nct02401451- Content hash
5a9e2b4f4220f800080c5f774c9983d725288fd91ee49a8deb3fbb3852e7ae7a